<VariationArchive VariationID="4134" VariationName="NC_000005.10:g.(?_177131798)_(177300213_)?)del" VariationType="Deletion" Accession="VCV000004134" Version="4" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-07-29" DateCreated="2017-09-28" MostRecentSubmission="2022-01-29">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="19173" VariationID="4134">
      <GeneList>
        <Gene Symbol="NSD1" FullName="nuclear receptor binding SET domain protein 1" GeneID="64324" HGNC_ID="HGNC:14234" Source="submitted" RelationshipType="asserted, but not computed">
          <Location>
            <CytogeneticLocation>5q35.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="5" Accession="NC_000005.10" start="177131798" stop="177300213" display_start="177131798" display_stop="177300213" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="5" Accession="NC_000005.9" start="176560079" stop="176727213" display_start="176560079" display_stop="176727213" Strand="+" />
          </Location>
          <OMIM>606681</OMIM>
          <Haploinsufficiency last_evaluated="2020-07-27" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=NSD1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-07-27" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=NSD1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NC_000005.10:g.(?_177131798)_(177300213_)?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>5q35</CytogeneticLocation>
      </Location>
      <OtherNameList>
        <Name>1.9-MB DEL</Name>
      </OtherNameList>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.10" sequenceAccession="NC_000005" sequenceVersion="10" change="(?_177131798)_(177300213_)?)del" Assembly="GRCh38">
            <Expression>NC_000005.10:(?_177131798)_(177300213_)?)del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000005.10" sequenceAccession="NC_000005" sequenceVersion="10" change="g.(?_177131798)_(177300213_)?)del" Assembly="GRCh38">
            <Expression>NC_000005.10:g.(?_177131798)_(177300213_)?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="606681.0001" DB="OMIM" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000005.10:g.(?_177131798)_(177300213_)?)del AND Sotos syndrome" Accession="RCV003231075" Version="8">
        <ClassifiedConditionList TraitSetID="32529">
          <ClassifiedCondition DB="MedGen" ID="C0175695">Sotos syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2006-01-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2006-01-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2017-09-28" MostRecentSubmission="2022-01-29">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11896389</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15580547</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16329110</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="32529" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="36672" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">CHROMOSOME 5q35 DELETION SYNDROME</ElementValue>
                <XRef Type="MIM" ID="117550" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cerebral gigantism</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Distinctive facial appearance, overgrowth in childhood, and learning disabilities or delayed development</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Sotos' syndrome</ElementValue>
                <XRef ID="Sotos+syndrome/6665" DB="Genetic Alliance" />
                <XRef ID="75968004" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Sotos syndrome</ElementValue>
                <XRef ID="MONDO:0019349" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS117550" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">SOTOS SYNDROME 1</ElementValue>
                <XRef Type="MIM" ID="117550" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">SOTOS</ElementValue>
                <XRef Type="MIM" ID="117550" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Sotos syndrome is characterized by a distinctive facial appearance (broad and prominent forehead with a dolichocephalic head shape, sparse frontotemporal hair, downslanting palpebral fissures, malar flushing, long and narrow face, long chin); learning disability (early developmental delay, mild-to-severe intellectual impairment); and overgrowth (height and/or head circumference â‰¥2 SD above the mean). These three clinical features are considered the cardinal features of Sotos syndrome. Major features of Sotos syndrome include behavioral problems (most notably autistic spectrum disorder), advanced bone age, cardiac anomalies, cranial MRI/CT abnormalities, joint hyperlaxity with or without pes planus, maternal preeclampsia, neonatal complications, renal anomalies, scoliosis, and seizures.</Attribute>
                <XRef ID="NBK1479" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10091" />
                <XRef ID="10091" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301652</ID>
                <ID Source="BookShelf">NBK1479</ID>
              </Citation>
              <XRef ID="821" DB="Orphanet" />
              <XRef ID="C0175695" DB="MedGen" />
              <XRef ID="MONDO:0019349" DB="MONDO" />
              <XRef Type="MIM" ID="117550" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="24521" SubmissionDate="2022-01-26" DateLastUpdated="2022-01-29" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="606681.0001_SOTOS SYNDROME" title="NSD1, 1.9-MB DEL_SOTOS SYNDROME" />
        <ClinVarAccession Accession="SCV000024521" DateUpdated="2022-01-29" DateCreated="2013-04-04" Type="SCV" Version="4" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2006-01-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 19 of 30 Japanese individuals with Sotos syndrome (SOTOS; 117550), Kurotaki et al. (2002) identified a 2.2-Mb deletion on chromosome 5q35 leading to complete deletion of the NSD1 gene.</Attribute>
              <Citation>
                <ID Source="PubMed">11896389</ID>
              </Citation>
              <XRef DB="OMIM" ID="117550" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Haploinsufficiency of the NSD1 gene owing to either intragenic mutations or microdeletions is the major cause of Sotos syndrome. The common microdeletion of approximately 2.2 Mb encompasses the whole NSD1 gene and neighboring genes and is flanked by low-copy repeats (LCRs). Visser et al. (2005) identified a 3.0-kb major recombination hotspot within these LCRs, in which they mapped deletion breakpoints in 78.7% (37/47) of patients with Sotos syndrome who carried the common microdeletion. They were able to refine the size of the deletion to 1.9 Mb. Sequencing of breakpoint fragments from all 37 patients revealed junctions between a segment of the proximal LCR (PLCR-B) and the corresponding region of the distal LCR (DLCR-2B). Visser et al. (2005) found that PLCR-B and DLCR-2B are the only directly oriented regions, whereas the remaining regions of the PLCR and DLCR are in inverted orientation. PLCR and DLCR showed high overall homology (approximately 98.5%), with an increased sequence similarity (approximately 99.4%) within the 3.0-kb breakpoint cluster.</Attribute>
              <Citation>
                <ID Source="PubMed">15580547</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In a female infant with features of both Sotos syndrome and Nevo syndrome (225400), Kanemoto et al. (2006) identified heterozygosity for a 2.2-Mb deletion encompassing the NSD1 gene.</Attribute>
              <Citation>
                <ID Source="PubMed">16329110</ID>
              </Citation>
              <XRef DB="OMIM" ID="225400" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NSD1" />
          </GeneList>
          <Name>NSD1, 1.9-MB DEL</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1.9-MB DEL</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="606681.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">SOTOS SYNDROME</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="24521" TraitType="Disease" MappingType="Name" MappingValue="SOTOS SYNDROME" MappingRef="Preferred">
        <MedGen CUI="C0175695" Name="Sotos syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

